Merck May 2013 Today, a group of public and private sector partners announced an agreement that will expand contraceptive access and options for millions of women in some of the world’s poorest countries. Under the agreement, Merck will reduce the Read More
Year: 2013
Press Release: GHIF announces final close
Global Health Investment Fund September 23, 2013 A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance Read More
Press Release: Indian manufacturer cuts price of childhood vaccine by 30 percent
Gavi: The Vaccine Alliance April 18, 2013 The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This Read More
Press Release: Innovative partnership reduces cost of Bayer’s long-acting reversible contraceptive implant by more than 50 percent
Bill & Melinda Gates Foundation February 27, 2013 An unprecedented group of public and private sector partners has finalized an agreement that will make Jadelle®, an effective, long-acting, reversible contraceptive implant, available to more than 27 million women in the Read More
Press Release: Anacor Pharmaceuticals receives significant investment to support neglected disease research
Anacor Pharmaceuticals April 8, 2013 Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or Read More